Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
Core EBITDA Margin

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 7.435.9613.0117.1421.17

What is the latest Core EBITDA Margin ratio of INDOCO REMEDIES ?

The latest Core EBITDA Margin ratio of INDOCO REMEDIES is 7.43 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar20267.43
Mar20255.96
Mar202413.01
Mar202317.14
Mar202221.17

How is Core EBITDA Margin of INDOCO REMEDIES Trending?

Years Core EBITDA Margin % Change
Mar2026 7.43
24.66
Mar2025 5.96
-54.19
Mar2024 13.01
-24.10
Mar2023 17.14
-19.04
Mar2022 21.17 -

Other Financial Ratios of INDOCO REMEDIES


Compare Core EBITDA Margin ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,430.3 Cr 4.8% 18.3% -8.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

4.8%

18.3%

-8.4%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses